Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Updated results of a randomized, double-blind, placebo-controlled, multicenter, phase III trial (RADIANT-3).

Authors

Jonathan Strosberg

H. Lee Moffitt Cancer Center & Research Institute

Jonathan Strosberg , Jeremie Lincy , Robert Winkler , Edward Wolin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Sign-In